Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

340 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

NCT04669600

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigational Site Number :8400001 Washington D.C., District of Columbia, United States
  • Investigational Site Number :8400002 Tamarac, Florida, United States
  • Investigational Site Number :2030002 Ostrava - Poruba, Czechia
  • Investigational Site Number :2760001 Essen, Germany
View Trial Details
Completed

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

NCT05438875

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
Locations
  • Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren hospital Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University Beijing, China
  • Department of Hematology, Beijing Hospital Beijing, China
View Trial Details
Completed

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

NCT03939637

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix CHildren's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 27 locations
View Trial Details
Completed

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

NCT04943042

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Swedish Orphan Biovitrum Research Site 131 Zagreb, Croatia
  • Swedish Orphan Biovitrum Research Site 122 Brno, Czechia
  • Swedish Orphan Biovitrum Research Site 123 Ostrava, Czechia
  • Swedish Orphan Biovitrum Research Site 121 Prague, Czechia
View all 55 locations
View Trial Details
Completed

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

NCT04278924

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Arizona Clinical Research Center - Hunt - PPDS Tucson, Arizona, United States
  • University of Florida Gainesville, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

NCT04346654

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
  • Novartis Investigative Site Aachen, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Donauwörth, Germany
View Trial Details

Related conditions